$ONCE (Spark Therapeutics, Inc.)

$ONCE {{ '2016-07-21T17:21:16+0000' | timeago}} • Announcement

$ONCE and $PFE said FDA granted breakthrough therapy designation to SPK-9001, which is being investigated in ongoing Phase 1/2 trial as potential one-time therapy, to treat rare genetic bleeding disorder hemophilia B. The designation is intended to expedite development and FDA review of drugs to treat serious or life-threatening disease.

$CELG {{ '2018-01-22T13:26:32+0000' | timeago}} • Announcement

Last week's rumor becomes reality. $CELG to acquire its strategic partner $JUNO for $9Bil. Juno Therapeutics, which had already skyrocketed nearly 50% in the last week, has increased more than 25% today in pre-market from Jan. 19th closing price of $67.81. Celgene expects that this deal will help it to boost the revenue generation beyond 2020.

$INFO {{ '2018-01-16T20:28:30+0000' | timeago}} • Infographic

$INFO IHS Markit Ltd. Earnings AlphaGraphic: Q4 2017 Highlights

$INFO {{ '2018-01-03T13:30:22+0000' | timeago}} • Announcement

$INFO appointed Lord Browne of Madingley and Nicoletta Giadrossi as new directors of the company. Also, Lance Uggla, the company’s president and COO, became chairman and CEO of $INFO on Jan. 1, 2018, following the retirement of chairman and CEO Jerre Stead on Dec. 31, 2017.

$CELG {{ '2017-12-11T14:27:28+0000' | timeago}} • Announcement

$CELG and $JUNO report additional data from the TRANSCEND study. Celgene added that the results of this study show the potential for the CAR T therapy, a therapy to treat cancers. Application filing is expected to be completed in 2H18, with approval as early as the end of 2018. In June 2015, Celgene partnered with Juno Therapeutics by paying $1Bil.

$INFO {{ '2017-12-04T12:52:38+0000' | timeago}} • Announcement

$INFO closed its offering of $500MM of senior notes due 2026 in a private placement transaction. $INFO plans to use the net proceeds from this offering to repay amounts outstanding under its revolving credit facility.

$INFO {{ '2017-11-30T13:08:02+0000' | timeago}} • Announcement

$INFO has priced an offering of $500MM  aggregate principal amount of senior notes due 2026. The offering is expected to close on December 1, 2017. The company intends to use the net proceeds from the offering to repay amounts outstanding under its revolving credit facility.

$SQ {{ '2017-11-08T22:09:54+0000' | timeago}} • Infographic

$SQ Square, Inc. Earnings AlphaGraphic: Q3 2017 Highlights

$FIT {{ '2017-11-01T20:32:01+0000' | timeago}} • Infographic

$FIT Fitbit Inc. Earnings AlphaGraphic: Q3 2017 Highlights

$PYPL {{ '2017-10-20T15:21:42+0000' | timeago}} • Webcast

$PYPL said it has some modest assumptions about monetizing Venmo going into 2018. The company is encouraged by the launch of Pay with Venmo with 2MM merchants currently and will continue to expand this. The 2018 guidance of approx. 20% revenue growth and 20% earnings growth includes some assumptions about Venmo.

$PYPL {{ '2017-10-20T15:06:29+0000' | timeago}} • Webcast

During 3Q17, $PYPL’s merchant services volume grew 34% on a currency neutral basis to $98.6Bil. This represented 86.5% of total volume. Volume associated with eBay represented 13.5% of the total compared to 16% for 3Q16. P2P volume, which is a component of merchant services, grew 47% to $24Bil and represented about 21% of total payment volume.

$PYPL {{ '2017-10-20T15:06:09+0000' | timeago}} • Webcast

$PYPL recently announced that Venmo's broad base of customers will now be able to pay with Venmo at over 2MM PayPal merchants across the United States. This is an important milestone for the company as it adds differentiated functionality for Venmo consumers and begins to monetize Venmo.

$PYPL {{ '2017-10-20T15:05:53+0000' | timeago}} • Webcast

$PYPL acquired 8.2MM net new active accounts in 3Q17, up almost 90% YoY. The company ended the period with 218MM active customer accounts with over 200MM consumers shopping at more than 17MM merchants. $PYPL currently expects to acquire close to 30MM net new active accounts in 2017.

$PYPL {{ '2017-10-19T21:54:35+0000' | timeago}} • Announcement

During 3Q17, $PYPL announced a partnership with Skype to allow users in 22 countries to send money to other Skype users with PayPal via their Skype mobile app. $PYPL also announced the expansion of its partnership with $MA into Canada, Europe, Latin America and the Caribbean and the Middle East and Africa. $PYPL acquired Swift Financial in 3Q17.

$PYPL {{ '2017-10-19T21:51:43+0000' | timeago}} • Announcement

For FY17, $PYPL expects revenue to grow 19-20% to $12.92-12.98Bil. GAAP EPS is expected to be $1.34-1.36 and adjusted EPS is expected to be $1.86-1.88. For 4Q17, $PYPL expects revenue to grow 20-22% to $3.57-3.63Bil. GAAP EPS is expected to be $0.37-0.39 and adjusted EPS is expected to be $0.50-0.52.

$PYPL {{ '2017-10-19T21:47:34+0000' | timeago}} • Announcement

$PYPL reported an 18% increase in 3Q17 earnings. Net income was $380MM or $0.31 per share compared to $323MM or $0.27 per share in 3Q16. GAAP EPS grew 17% during 3Q17. Adjusted net income was $560MM or $0.46 per share in 3Q17. Net revenues grew 21% to $3.23Bil versus last year.

$PYPL {{ '2017-10-19T21:06:26+0000' | timeago}} • Infographic

$PYPL PayPal Holdings Inc. Earnings AlphaGraphic: Q3 2017 Highlights

$SGMO {{ '2017-10-02T16:06:18+0000' | timeago}} • Announcement

$SGMO and $BIVV said the FDA has accepted the Investigational New Drug (IND) application for ST-400, a gene-edited cell therapy candidate for people with transfusion-dependent beta-thalassemia. $SGMO expects to open several clinical sites across the United States and begin enrolling patients in 1H18.

$SGMO {{ '2017-10-02T16:05:15+0000' | timeago}} • Announcement

$SGMO and $BIVV said the FDA has accepted the Investigational New Drug (IND) application for ST-400, a gene-edited cell therapy candidate for people with transfusion-dependent beta-thalassemia. This is as part of exclusive worldwide collaboration to develop and commercialize gene-edited cell therapies for beta-thalassemia and sickle cell disease.

$PYPL {{ '2017-09-27T16:46:54+0000' | timeago}} • Announcement

$PYPL has appointed Rodney C. Adkins to its BoD. Mr. Adkins will serve on $PYPL’s Audit, Risk and Compliance Committee. His appointment was effective September 26, 2017. Mr. Adkins is President of 3RAM Group LLC, a privately-held company specializing in capital investments, business consulting services and property management.

$INFO {{ '2017-09-26T13:19:34+0000' | timeago}} • Announcement

$INFO, a provider of analytics and solutions to enterprises, has acquired majority stake in automotiveMastermind Inc., a technology company in the automotive industry, for about $392MM. IHS will acquire the remaining 22% of automotiveMastermind's stock over the next five years, based on valuation tied to underlying business performance.

Recent Transcripts

INFO (IHS Markit Ltd.)
Tuesday, January 16 2018 - 1:00pm
HQY (HealthEquity, Inc.)
Tuesday, December 5 2017 - 10:00pm
SGMO (Sangamo Biosciences Inc.)
Thursday, November 9 2017 - 10:00pm
SQ (Square, Inc.)
Wednesday, November 8 2017 - 10:00pm
WEB (Web.com Group, Inc.)
Tuesday, November 7 2017 - 10:00pm
APPS (Digital Turbine, Inc.)
Tuesday, November 7 2017 - 9:30pm
ONCE (Spark Therapeutics, Inc.)
Tuesday, November 7 2017 - 1:30pm
GTT (GTT Communications, Inc.)
Thursday, November 2 2017 - 2:00pm
FIT (Fitbit Inc.)
Wednesday, November 1 2017 - 9:00pm
JUNO (Juno Therapeutics Inc.)
Wednesday, November 1 2017 - 8:30pm
PYPL (PayPal Holdings, Inc.)
Thursday, October 19 2017 - 9:00pm
INFO (IHS Markit Ltd.)
Tuesday, September 26 2017 - 12:00pm
HQY (HealthEquity, Inc.)
Tuesday, September 5 2017 - 9:00pm
SGMO (Sangamo Biosciences Inc.)
Wednesday, August 9 2017 - 9:00pm
APPS (Digital Turbine, Inc.)
Monday, August 7 2017 - 8:30pm
JUNO (Juno Therapeutics Inc.)
Thursday, August 3 2017 - 9:00pm
WEB (Web.com Group, Inc.)
Thursday, August 3 2017 - 9:00pm
GTT (GTT Communications, Inc.)
Thursday, August 3 2017 - 2:00pm
FIT (Fitbit Inc.)
Wednesday, August 2 2017 - 9:00pm
SQ (Square, Inc.)
Wednesday, August 2 2017 - 9:00pm

AlphaGraphics you may like